Form 8-K - Current report:
SEC Accession No. 0001493152-24-014883
Filing Date
2024-04-16
Accepted
2024-04-16 17:27:39
Documents
16
Period of Report
2024-04-11
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 49646
2 ex7-1.htm EX-7.1 3653
  Complete submission text file 0001493152-24-014883.txt   276936

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cdt-20240411.xsd EX-101.SCH 3883
4 XBRL DEFINITION FILE cdt-20240411_def.xml EX-101.DEF 26778
5 XBRL LABEL FILE cdt-20240411_lab.xml EX-101.LAB 37007
6 XBRL PRESENTATION FILE cdt-20240411_pre.xml EX-101.PRE 25402
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6079
Mailing Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123
Business Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 (760) 471 8536
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41245 | Film No.: 24848801
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)